Julio Ancochea
Distinguished in Chronic Obstructive Pulmonary Disease (COPD)

Julio Ancochea

Madrid, MD, ES 
Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Madrid, MD, ES 
OverviewLocationsClinical Research

Overview

Julio Ancochea practices in Madrid, Spain. Mr. Ancochea is rated as a Distinguished expert by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), COVID-19, Idiopathic Pulmonary Fibrosis, Lymphangioleiomyomatosis, and Lung Transplant.

His clinical research consists of co-authoring 154 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 53 articles in the study of Chronic Obstructive Pulmonary Disease (COPD).

Gender
Male

Locations

Madrid, MD, Spain
Other Locations
Spain
Sevilla, AN, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Extension Study in a Cohort of Adult Patients With SARS-CoV-2 Infection Requiring Hospital Admission and Received Treatment With Plitidepsin in the APLICOV-PC Study
Extension Study in a Cohort of Adult Patients With SARS-CoV-2 Infection Requiring Hospital Admission and Received Treatment With Plitidepsin in the APLICOV-PC Study
Enrollment Status: Completed
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Plitidepsin
Study Phase: Phase 1/Phase 2
Multicenter, Randomized, Parallel and Proof of Concept Study to Evaluate the Safety Profile of Three Doses of Plitidepsin in Patients With COVID-19 Requiring Hospitalization
Multicenter, Randomized, Parallel and Proof of Concept Study to Evaluate the Safety Profile of Three Doses of Plitidepsin in Patients With COVID-19 Requiring Hospitalization
Enrollment Status: Completed
Publish Date: August 23, 2022
Intervention Type: Drug
Study Phase: Phase 1
Phase II Clinical Trial to Explore the Efficacy of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With Severe Pulmonary Involvement by COVID-19
Phase II Clinical Trial to Explore the Efficacy of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With Severe Pulmonary Involvement by COVID-19
Enrollment Status: Withdrawn
Publish Date: August 27, 2021
Intervention Type: Drug, Biological
Study Drug: Mesenchymal cells
Study Phase: Phase 2
View 2 Less Clinical Trials

154 Total Publications

The Role of Triple CFTR Modulator Therapy in Reducing Systemic Inflammation in Cystic Fibrosis.
The Role of Triple CFTR Modulator Therapy in Reducing Systemic Inflammation in Cystic Fibrosis.
Journal: Lung
Published: January 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ancochea's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile